Pyrrolo[1,2-b][1,2,5]benzothiadiazepines (PBTDs): a New Class of Agents endowed with High Apoptotic Activity in Chronic Myelogenous Leukemia K562 Cells and in Cells from Patients at Onset and Imatinib-Resistant.